Evidence map›Paper›PMID 17826637›Full record

ReviewNeuroimaging clinics of North America2007

Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial.

Colin P Derdeyn, Marc I Chimowitz

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Neuroimaging clinics of North America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00816166 (Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00816166 phase2 / phase3terminatednot on this mapstarted 2008, after this paper: background citation

Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease

TypeinterventionalSponsorCodman & ShurtleffRan2008 to 2014Enrolled125ConditionsIschemic Stroke, Transient Ischemic AttackArmsPharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel), Aspirin and Clopidogrel (Medical therapy)
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Primary angioplasty for symptomatic atherosclerotic middle cerebral artery stenosis.Journal of cerebrovascular and endovascular neurosurgery · 2014
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Intracranial atherosclerotic disease.Stroke research and treatment · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Colin P DerdeynMallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Blvd, St. Louis, MO 63110, USA. derdeync@wustl.edu
Marc I Chimowitz
Emory University · USMallinckrodt (United States) · US

Funding

WARFARIN VS ASPIRIN FOR INTRACRANIAL ARTERIAL STENOSISR01NS036643 · NINDS · EMORY UNIVERSITY · PI CHIMOWITZ, MARC IVOR · 1998 to 2002
$9.1M
The Role of Cerebral Hemodynamics in Moya Moya DiseaseR01NS051631 · NINDS · WASHINGTON UNIVERSITY · PI DERDEYN, COLIN PIETER · 2006 to 2010
$1.6M
Intracranial Stents for Arterial StenosisK24NS050307 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHIMOWITZ, MARC IVOR · 2005 to 2009
$697k
PRAISE StudyR01NS051688 · NINDS · EMORY UNIVERSITY · PI CHIMOWITZ, MARC IVOR · 2005 to 2005
$378k
NINDS NIH HHS K24 NS050307NINDS NIH HHS R01 NS036643NINDS NIH HHS R01 NS051631NINDS NIH HHS R01 NS051688
6 · The paper itself

Abstract

Atherosclerotic disease of the major intracranial arteries is a frequent cause of stroke. In addition, many patients who have symptomatic intracranial stenosis are at very high risk for recurrent stroke. Preliminary studies suggest that angioplasty and stenting may reduce the risk of stroke in patients who have severe stenosis of intracranial arteries. Data for angioplasty and stenting, however, consist of case series; no randomized studies have been completed to date. This article reviews these data and discusses the rationale for a randomized trial of angioplasty and stenting versus best medical management for patients who have symptomatic intracranial stenosis.

Indexed as

StentsAngioplastyAnticoagulantsBrainCarotid ArteriesCarotid StenosisCerebral ArteriesConstriction, PathologicHumansIntracranial ArteriosclerosisRandomized Controlled Trials as TopicAnticoagulants

Identifiers

PMID17826637
PMCPMC2040119
OpenAlexW2023234688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.